G. Aumais

发表

IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes

David C. Wilson, Judy H. Cho, C. Gieger, 2018, Nature Communications.

FUT2 genotype and secretory status are not associated with fecal microbial composition and inferred function in healthy subjects

A. Paterson, P. Moayyedi, M. Silverberg, 2018, Gut microbes.

Comparative performances of machine learning methods for classifying Crohn Disease patients using genome-wide genotyping data

Judy H. Cho, John P. Ferguson, G. Wainrib, 2019, Scientific Reports.

Review and clinical perspectives for the use of infliximab in ulcerative colitis.

A. Griffiths, A. Bitton, G. Greenberg, 2008, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

Canadian Association of Gastroenterology Clinical Practice Guidelines: the use of infliximab in Crohn's disease.

H. Steinhart, A. Griffiths, A. Bitton, 2004, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

Increased Intestinal Permeability is Associated with Later Development of Crohn's Disease.

A. Paterson, M. Surette, C. Lees, 2020, Gastroenterology.

High density mapping of the MHC identifies a shared role for HLA-DRB1*01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis

Hailiang Huang, Stephan Ripke, Andre Franke, 2014, Nature Genetics.

The probiotic VSL#3 has anti-inflammatory effects and could reduce endoscopic recurrence after surgery for Crohn's disease.

A. Bitton, C. Bernstein, R. Enns, 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Comparative performances of machine learning methods for classifying Crohn Disease patients using genome-wide genotyping data

Judy H. Cho, John P. Ferguson, G. Wainrib, 2019, Scientific Reports.

Phenotypic and Genotypic Characteristics of Inflammatory Bowel Disease in French Canadians: Comparison With a Large North American Repository

Judy H. Cho, J. Rioux, M. Silverberg, 2009, The American Journal of Gastroenterology.

Analysis of Genetic Association of Intestinal Permeability in Healthy First-degree Relatives of Patients with Crohn's Disease.

M. Surette, P. Moayyedi, G. Kaplan, 2019, Inflammatory bowel diseases.

Association of host genome with intestinal microbial composition in a large healthy cohort

A. Paterson, P. Moayyedi, G. Kaplan, 2016, Nature Genetics.

Gene-centric association mapping of chromosome 3p implicates MST1 in IBD pathogenesis

M. Silverberg, K. Taylor, C. Lefebvre, 2008, Mucosal Immunology.

Pharmacokinetics and Pilot Efficacy of a Mesalazine Rectal Gel in Distal Ulcerative Colitis

M. Grace, G. Aumais, C. Tremblay, 2005, Drugs in R&D.

Rectal tissue, plasma and urine concentrations of mesalazine after single and multiple administrations of 500 mg suppositories to healthy volunteers and ulcerative proctitis patients

G. Aumais, C. Tremblay, F. Martin, 2003, Alimentary pharmacology & therapeutics.

Immune response and barrier dysfunction-related proteomic signatures in preclinical phase of Crohn’s disease highlight earliest events of pathogenesis

P. Moayyedi, M. Silverberg, A. Griffiths, 2023, Gut.

Altered gut microbiome composition and function are associated with gut barrier dysfunction in healthy relatives of patients with Crohn's disease.

P. Moayyedi, A. Griffiths, A. Steinhart, 2022, Gastroenterology.

Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study.

Teck Kiang Tan, J. Mansfield, Fraser Cummings, 2021, The lancet. Gastroenterology & hepatology.

Novel fecal biomarkers that precede clinical diagnosis of ulcerative colitis.

P. Moayyedi, G. Kaplan, M. Silverberg, 2020, Gastroenterology.

A Pleiotropic Missense Variant in SLC39A8 Is Associated With Crohn's Disease and Human Gut Microbiome Composition.

Judy H. Cho, M. Daly, L. Klei, 2016, Gastroenterology.

A pleiotropic missense variant in SLC 39 A 8 is associated with Crohn ’ s disease and human gut microbiome composition Short Title : SLC 39 A 8 associated with CD and gut microbiome

Judy H. Cho, M. Daly, L. Klei, 2016 .

Anti-microbial antibody response is associated with future onset of Crohn's disease independent of biomarkers of altered gut barrier function, subclinical inflammation, and genetic risk.

A. Paterson, P. Moayyedi, M. Silverberg, 2021, Gastroenterology.

Associations of NOD2 polymorphisms with Erysipelotrichaceae in stool of in healthy first degree relatives of Crohn’s disease subjects

A. Paterson, P. Moayyedi, M. Silverberg, 2020, BMC medical genetics.

Cost-effectiveness of golimumab for the treatment of patients with moderate-to-severe ulcerative colitis in Quebec using a patient level state transition microsimulation

A. Cohen, E. Rahme, G. Aumais, 2018, Journal of medical economics.

Mediterranean-like dietary pattern associations with gut microbiome composition and sub-clinical gastrointestinal inflammation.

A. Paterson, P. Moayyedi, M. Silverberg, 2022, Gastroenterology.

Su1012 Canadian Patient and Caregiver Perspectives on Subsequent Entry Biologics/Biosimilars for Inflammatory Bowel Disease

J. Marshall, R. Panaccione, G. Aumais, 2016 .

Patterns and predictors of long-term retention of inflammatory bowel or rheumatoid disease patients on innovator infliximab: an analysis of a Canadian prescriptions claims database

J. Marshall, R. Panaccione, M. Khraishi, 2018, Patient preference and adherence.

High-density mapping of the MHC identifies a shared role for HLA-DRB1*01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis

Judy H. Cho, C. Gieger, H. Hakonarson, 2015 .

Comparative performances of machine learning methods for classifying Crohn Disease patients using genome-wide genotyping data

Lisa, Husam, John P. Ferguson, 2023 .

Gut Microbiome Composition is associated with future onset of Crohn's Disease in Healthy First-Degree Relatives.

P. Moayyedi, M. Silverberg, A. Griffiths, 2023, Gastroenterology.

Understanding Predictors of Crohn’s Disease: Determinants of Altered Barrier Function in Pre-Disease Phase of Crohn’s Disease

P. Moayyedi, G. Kaplan, M. Silverberg, 2024, Journal of the Canadian Association of Gastroenterology.

Canadian Association of Gastroenterology Clinical Practice Guidelines: the use of infliximab in Crohn's disease.

H. Steinhart, A. Bitton, R. Enns, 2004, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.